Patients With Cancer
7
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer
Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients
Shared Meditation Involving People With Cancer, Carers and Third Parties
Autologous Immune Enhancement Therapy (AIET) for Cancer Patients
Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
Radioimmunotherapy With 131I-L19SIP in Patients With Cancer